Skip to main content

Table 1 Baseline characteristics and parameters between two groups

From: Factors associated with serum fetuin-A concentrations after long-term use of different phosphate binders in hemodialysis patients

  Sevelamer
(n = 23)
Calcium Carbonate
(n = 27)
P
Age (yr) 59.61 ± 8.16 56.96 ± 7.72 0.248
Gender (male) 11 (47.83 %) 18 (66.67 %) 0.149
Hemodialysis (yr) 7.00 (5) 5.00 (4) 0.313
DM (no) 9 (39.13 %) 8 (29.63 %) 0.557
Use of vitamin D (no) 9 (39.13 %) 13 (48.14 %) 0.577
Use of vitamin D (months) 77 81 0.775
LCB (no) 7 (30.43 %) 6 (22.22 %) 0.537
Statin (no) 7 (30.43 %) 5 (18.52 %) 0.305
Anti-hypertension drug (no) 16 (69.56 %) 20 (74.07 %) 0.761
Ca (mg/dL) 9.37 ± 0.66 9.37 ± 0.73 0.986
P (mg/dL) 6.54 ± 0.91 7.22 ± 0.98 0.015*
iPTH (pg/mL) 354.70 (332.70) 320.90 (371.8) 0.633
ALK-P (IU/L) 82.17 ± 32.71 65.67 ± 23.70 0.061
HsCRP (mg/L) 2.3 (5.8) 3.10 (6.1) 0.697
Hct (%) 33.10 ± 3.87 32.49 ± 3.11 0.549
Albumin (g/L) 39.92 ± 3.13 39.81 ± 2.86 0.866
TG (mg/dL) 98.00 (86.00) 113.00 (127.00) 0.459
LDL-C (mg/dL) 108.96 ± 30.10 112.93 ± 33.46 0.661
Fetuin-A (ug/mL) 210.61 (104.73) 203.95 (107.87) 0.961
  1. Data are mean ± standard deviation or median (interquartile range, IQR)
  2. Vitamin D: active vitamin D, either alfacalcidol or calcitriol
  3. LCB: low calcium bath (Ca 2.5 meq/L); non-LCB: Ca 3.0 meq/L or 3.5 meq/L
  4. P < 0.05*